Iridex (IRIX) Divestments (2012 - 2013)
Iridex's (IRIX) quarterly Divestments came in at $510000.0 in Q2 2013, down 88.99% quarter-over-quarter from $4.6 million in Q1 2012.
Iridex (IRIX) Divestments (2012 - 2013) Analysis & Trends
Iridex's Divestments history runs 2 years deep, the most recent figure standing at $510000.0 for Q2 2013.
- On a quarterly basis, Divestments changed N/A year-over-year to $510000.0 in Q2 2013; TTM through Dec 2013 was $510000.0, a 88.99% decrease from a year earlier, with the FY2013 full-year figure at $510000.0, down 88.99% from the prior year.
- Divestments slipped to $510000.0 in Q2 2013 per IRIX's latest filing, from $4.6 million in the prior quarter.
- Across five years, Divestments topped out at $4.6 million in Q1 2012 and bottomed at $510000.0 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 9.37 Mn |
| 10 | Iridex | 15.20 Mn | 10.60 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 29, 2013 | 510,000.00 |
| Mar 31, 2012 | 4.63 Mn |